<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">inhibitors </span>
   <span class="font25">inhibitor </span>
   <span class="font21">furin </span>
   <span class="font20">protease </span>
   <span class="font19">proteases </span>
   <span class="font19">virus </span>
   <span class="font18">serine </span>
   <span class="font17">human </span>
   <span class="font17">influenza </span>
   <span class="font15">Fig. </span>
   <span class="font15">inhibition </span>
   <span class="font15">potent </span>
   <span class="font15">cleavage </span>
   <span class="font15">matriptase </span>
   <span class="font15">host </span>
   <span class="font14">trypsin-like </span>
   <span class="font14">TMPRSS </span>
   <span class="font14">Med </span>
   <span class="font14">treatment </span>
   <span class="font14">complex </span>
   <span class="font14">inhibits </span>
   <span class="font14">trypsin </span>
   <span class="font14">analogue </span>
   <span class="font14">cysteine </span>
   <span class="font13">(Fig. </span>
   <span class="font13">binding </span>
   <span class="font13">site </span>
   <span class="font13">activation </span>
   <span class="font13">cell </span>
   <span class="font13">structure </span>
   <span class="font13">numerous </span>
   <span class="font13">antiviral </span>
   <span class="font13">cells </span>
   <span class="font13">containing </span>
   <span class="font13">like </span>
   <span class="font13">value </span>
   <span class="font13">substrate </span>
   <span class="font13">(Ki </span>
   <span class="font13">However, </span>
   <span class="font13">cathepsin </span>
   <span class="font13">compound </span>
   <span class="font13">compounds </span>
   <span class="font13">reduced </span>
   <span class="font12">Chem </span>
   <span class="font12">SKI-/SP </span>
   <span class="font12">residues </span>
   <span class="font12">used </span>
   <span class="font12">{border-style </span>
   <span class="font12">Biol </span>
   <span class="font12">PCs </span>
   <span class="font12">drug </span>
   <span class="font12">factor </span>
   <span class="font12">pocket </span>
   <span class="font12">shown </span>
   <span class="font12">viral </span>
   <span class="font12">Inhibitors </span>
   <span class="font12">basic </span>
   <span class="font12">crystal </span>
   <span class="font12">proprotein </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">active </span>
   <span class="font12">processing </span>
   <span class="font12">protein </span>
   <span class="font12">viruses </span>
   <span class="font12">PC, </span>
   <span class="font12">described </span>
   <span class="font12">development </span>
   <span class="font12">mice </span>
   <span class="font12">potency </span>
   <span class="font12">structures </span>
   <span class="font12">glycoprotein </span>
   <span class="font12">inhibit </span>
   <span class="font12">involved </span>
   <span class="font12">peptide </span>
   <span class="font12">selective </span>
   <span class="font12">surface </span>
   <span class="font12">thrombin </span>
   <span class="font12">Virol./JVI.- </span>
   <span class="font12">active-site </span>
   <span class="font12">analogues </span>
   <span class="font12">covalent </span>
   <span class="font12">proteases. </span>
   <span class="font12">relatively </span>
   <span class="font12">substrates </span>
   <span class="font12">suitable </span>
   <span class="font12">type </span>
   <span class="font11">additional </span>
   <span class="font11">values </span>
   <span class="font11">derivatives </span>
   <span class="font11">design </span>
   <span class="font11">group </span>
   <span class="font11">nM) </span>
   <span class="font11">potential </span>
   <span class="font11">residue </span>
   <span class="font11">target </span>
   <span class="font11">targeting </span>
   <span class="font11">targets </span>
   <span class="font11">(Basak </span>
   <span class="font11">IAV </span>
   <span class="font11">amino </span>
   <span class="font11">binds </span>
   <span class="font11">catalytic </span>
   <span class="font11">constant </span>
   <span class="font11">coronavirus </span>
   <span class="font11">domain </span>
   <span class="font11">fusion </span>
   <span class="font11">receptor </span>
   <span class="font11">similar </span>
   <span class="font11">specific </span>
   <span class="font11">studies </span>
   <span class="font11">Moreover, </span>
   <span class="font11">PACE </span>
   <span class="font11">airway </span>
   <span class="font11">aprotinin </span>
   <span class="font11">arginine </span>
   <span class="font11">derivative </span>
   <span class="font11">drugs </span>
   <span class="font11">enzyme </span>
   <span class="font11">furin, </span>
   <span class="font11">high </span>
   <span class="font11">including </span>
   <span class="font11">inhibitors, </span>
   <span class="font11">known </span>
   <span class="font11">membrane </span>
   <span class="font11">model </span>
   <span class="font11">new </span>
   <span class="font11">novel </span>
   <span class="font11">replication </span>
   <span class="font11">small-molecule </span>
   <span class="font11">therapeutic </span>
   <span class="font11">transmembrane </span>
   <span class="font11">vitro </span>
   <span class="font11">(PDB, </span>
   <span class="font11">-mer </span>
   <span class="font11">Furthermore, </span>
   <span class="font11">N-terminal </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">TTSPs </span>
   <span class="font11">activated </span>
   <span class="font11">activity </span>
   <span class="font11">affinity </span>
   <span class="font11">approved </span>
   <span class="font11">broad-spectrum </span>
   <span class="font11">cancer </span>
   <span class="font11">carbon </span>
   <span class="font11">different </span>
   <span class="font11">e.g., </span>
   <span class="font11">enzymes </span>
   <span class="font11">family </span>
   <span class="font11">growth </span>
   <span class="font11">hemagglutinin </span>
   <span class="font11">infection </span>
   <span class="font11">irreversible </span>
   <span class="font11">leads </span>
   <span class="font11">monobasic </span>
   <span class="font11">nM, </span>
   <span class="font11">peptidic </span>
   <span class="font11">position </span>
   <span class="font11">possess </span>
   <span class="font11">proteases, </span>
   <span class="font11">respiratory </span>
   <span class="font11">strongly </span>
   <span class="font11">.). </span>
   <span class="font11">Acad </span>
   <span class="font11">Biophys </span>
   <span class="font11">Chem./jbc.M </span>
   <span class="font11">Despite </span>
   <span class="font11">Drug </span>
   <span class="font11">Furin </span>
   <span class="font11">Host </span>
   <span class="font11">Rev </span>
   <span class="font11">SFTI- </span>
   <span class="font11">Structures </span>
   <span class="font11">TMPRSS, </span>
   <span class="font11">achieved </span>
   <span class="font11">atoms </span>
   <span class="font11">backbone </span>
   <span class="font11">clinical </span>
   <span class="font11">combination </span>
   <span class="font11">distal </span>
   <span class="font11">effect </span>
   <span class="font11">effects </span>
   <span class="font11">efficacy </span>
   <span class="font11">far, </span>
   <span class="font11">furin-like </span>
   <span class="font11">highly </span>
   <span class="font11">inhibitory </span>
   <span class="font11">low </span>
   <span class="font11">nonpeptidic </span>
   <span class="font11">observed </span>
   <span class="font11">plasma </span>
   <span class="font11">provided </span>
   <span class="font11">px; </span>
   <span class="font11">reversible </span>
   <span class="font11">second </span>
   <span class="font11">sequence </span>
   <span class="font11">sequences </span>
   <span class="font11">small </span>
   <span class="font11">spike </span>
   <span class="font11">strategy </span>
   <span class="font11">synthetic </span>
   <span class="font11">trypsin, </span>
   <span class="font11">use </span>
   <span class="font11">{font-family </span>
   <span class="font11">Ebola </span>
   <span class="font11">Lett./j.bmcl... </span>
   <span class="font11">Trp </span>
   <span class="font11">Virus </span>
   <span class="font11">acid </span>
   <span class="font11">acute </span>
   <span class="font11">addressing </span>
   <span class="font11">available </span>
   <span class="font11">based </span>
   <span class="font11">cathepsins </span>
   <span class="font11">clotting </span>
   <span class="font11">contrast, </span>
   <span class="font11">convertase </span>
   <span class="font11">derived </span>
   <span class="font11">developed </span>
   <span class="font11">enhanced </span>
   <span class="font11">font-size </span>
   <span class="font11">form </span>
   <span class="font11">groups </span>
   <span class="font11">important </span>
   <span class="font11">infected </span>
   <span class="font11">inhibitor, </span>
   <span class="font11">inhibitors. </span>
   <span class="font11">instance, </span>
   <span class="font11">mode </span>
   <span class="font11">molecule </span>
   <span class="font11">peptides </span>
   <span class="font11">polar </span>
   <span class="font11">proteolytic </span>
   <span class="font11">selectivity </span>
   <span class="font11">severe </span>
   <span class="font11">significant </span>
   <span class="font11">spread </span>
   <span class="font11">stable </span>
   <span class="font11">tested </span>
   <span class="font11">using </span>
   <span class="font11">various </span>
   <span class="font10">(), </span>
   <span class="font10">(Dahms </span>
   <span class="font10">-Amba </span>
   <span class="font10">Based </span>
   <span class="font10">C-terminal </span>
   <span class="font10">HAT, </span>
   <span class="font10">Influenza </span>
   <span class="font10">Natl </span>
   <span class="font10">Numerous </span>
   <span class="font10">Res </span>
   <span class="font10">Sci </span>
   <span class="font10">Serine </span>
   <span class="font10">Therefore, </span>
   <span class="font10">activate </span>
   <span class="font10">activating </span>
   <span class="font10">activator </span>
   <span class="font10">belongs </span>
   <span class="font10">blocks </span>
   <span class="font10">cellular </span>
   <span class="font10">chain </span>
   <span class="font10">cleaved </span>
   <span class="font10">close </span>
   <span class="font10">contrast </span>
   <span class="font10">convertases </span>
   <span class="font10">double; </span>
   <span class="font10">epithelial </span>
   <span class="font10">examples </span>
   <span class="font10">improved </span>
   <span class="font10">inhibitorsJ </span>
   <span class="font10">interactions </span>
   <span class="font10">knockout </span>
   <span class="font10">mainly </span>
   <span class="font10">nitrile </span>
   <span class="font10">oral </span>
   <span class="font10">oxygen </span>
   <span class="font10">plasmin, </span>
   <span class="font10">prepared </span>
   <span class="font10">propagation </span>
   <span class="font10">proteins </span>
   <span class="font10">reached </span>
   <span class="font10">red </span>
   <span class="font10">risk </span>
   <span class="font10">series </span>
   <span class="font10">sites </span>
   <span class="font10">strains </span>
   <span class="font10">strong </span>
   <span class="font10">structure-based </span>
   <span class="font10">tumor </span>
   <span class="font10">vivo </span>
   <span class="font10">(Becker </span>
   <span class="font10">(Cameron </span>
   <span class="font10">(Hardes </span>
   <span class="font10">(Seidah </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Asp </span>
   <span class="font10">Cell </span>
   <span class="font10">Crystal </span>
   <span class="font10">HAT </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Mol </span>
   <span class="font10">Nipah </span>
   <span class="font10">PACE, </span>
   <span class="font10">PCSK </span>
   <span class="font10">PF- </span>
   <span class="font10">Proteases </span>
   <span class="font10">Structure </span>
   <span class="font10">address </span>
   <span class="font10">and/or </span>
   <span class="font10">anthrax </span>
   <span class="font10">approximately </span>
   <span class="font10">bind </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">camostat </span>
   <span class="font10">characteristic </span>
   <span class="font10">characterization </span>
   <span class="font10">chloromethyl </span>
   <span class="font10">constants </span>
   <span class="font10">contacts </span>
   <span class="font10">cultures </span>
   <span class="font10">direct </span>
   <span class="font10">effects. </span>
   <span class="font10">efficiently </span>
   <span class="font10">endosomal </span>
   <span class="font10">enzymes, </span>
   <span class="font10">excellent </span>
   <span class="font10">extracellular </span>
   <span class="font10">far. </span>
   <span class="font10">glycine </span>
   <span class="font10">intracellular </span>
   <span class="font10">isolated </span>
   <span class="font10">leading </span>
   <span class="font10">lower </span>
   <span class="font10">lysine </span>
   <span class="font10">matriptase, </span>
   <span class="font10">moderate </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">multibasic </span>
   <span class="font10">nanomolar </span>
   <span class="font10">natural </span>
   <span class="font10">obtained </span>
   <span class="font10">optimization </span>
   <span class="font10">orally </span>
   <span class="font10">pathogenic </span>
   <span class="font10">phase </span>
   <span class="font10">presence </span>
   <span class="font10">prodomain </span>
   <span class="font10">prodrug </span>
   <span class="font10">rat </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">recognition </span>
   <span class="font10">related </span>
   <span class="font10">required </span>
   <span class="font10">residue, </span>
   <span class="font10">respectively. </span>
   <span class="font10">revealed </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">scaffold </span>
   <span class="font10">shows </span>
   <span class="font10">solid; </span>
   <span class="font10">soluble </span>
   <span class="font10">stronger </span>
   <span class="font10">study </span>
   <span class="font10">suggested </span>
   <span class="font10">sunflower </span>
   <span class="font10">thrombin, </span>
   <span class="font10">toxin </span>
   <span class="font10">viruses, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Böttcher-Friebertshäuser </span>
   <span class="font10">(Goswami </span>
   <span class="font10">(Hammami </span>
   <span class="font10">(Maiwald </span>
   <span class="font10">(Siklos </span>
   <span class="font10">(Steinmetzer </span>
   <span class="font10">(Zhirnov </span>
   <span class="font10">-amidinobenzylamide </span>
   <span class="font10">A./pnas. </span>
   <span class="font10">ACE </span>
   <span class="font10">AEBSF </span>
   <span class="font10">CMK </span>
   <span class="font10">CoV </span>
   <span class="font10">Compound </span>
   <span class="font10">Consequently, </span>
   <span class="font10">DPP </span>
   <span class="font10">Discov./nrd </span>
   <span class="font10">ECA </span>
   <span class="font10">HIV- </span>
   <span class="font10">Hardes </span>
   <span class="font10">LASV </span>
   <span class="font10">Lys </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Matriptase </span>
   <span class="font10">Opin </span>
   <span class="font10">P-P </span>
   <span class="font10">PCs. </span>
   <span class="font10">Prat </span>
   <span class="font10">Proprotein </span>
   <span class="font10">Protease </span>
   <span class="font10">Res./j.antiviral... </span>
   <span class="font10">Table </span>
   <span class="font10">activates </span>
   <span class="font10">activity. </span>
   <span class="font10">addition, </span>
   <span class="font10">adjacent </span>
   <span class="font10">aerosol </span>
   <span class="font10">amides </span>
   <span class="font10">approach </span>
   <span class="font10">avian </span>
   <span class="font10">b). </span>
   <span class="font10">better </span>
   <span class="font10">bicyclic </span>
   <span class="font10">bioavailability </span>
   <span class="font10">block </span>
   <span class="font10">blocked </span>
   <span class="font10">blue, </span>
   <span class="font10">bold </span>
   <span class="font10">breast </span>
   <span class="font10">case </span>
   <span class="font10">cells. </span>
   <span class="font10">certain </span>
   <span class="font10">cleavages </span>
   <span class="font10">compared </span>
   <span class="font10">complexed </span>
   <span class="font10">complexes </span>
   <span class="font10">concentrations </span>
   <span class="font10">contact </span>
   <span class="font10">contain </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">cycle </span>
   <span class="font10">decarboxylated </span>
   <span class="font10">determined </span>
   <span class="font10">development. </span>
   <span class="font10">discovery </span>
   <span class="font10">domains </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">experimental </span>
   <span class="font10">expression </span>
   <span class="font10">failed </span>
   <span class="font10">field </span>
   <span class="font10">following </span>
   <span class="font10">function </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">hepatocyte </span>
   <span class="font10">hepsin, </span>
   <span class="font10">identified </span>
   <span class="font10">inactive </span>
   <span class="font10">incorporation </span>
   <span class="font10">infections. </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibited </span>
   <span class="font10">initial </span>
   <span class="font10">interaction </span>
   <span class="font10">kallikrein </span>
   <span class="font10">ketones </span>
   <span class="font10">lead </span>
   <span class="font10">localization </span>
   <span class="font10">makes </span>
   <span class="font10">measles </span>
   <span class="font10">modification </span>
   <span class="font10">motif </span>
   <span class="font10">mutation </span>
   <span class="font10">nM. </span>
   <span class="font10">nanobodies </span>
   <span class="font10">nitrogen </span>
   <span class="font10">patients </span>
   <span class="font10">peptidase </span>
   <span class="font10">physiological </span>
   <span class="font10">plasmin </span>
   <span class="font10">poor </span>
   <span class="font10">possesses </span>
   <span class="font10">possible </span>
   <span class="font10">precursor </span>
   <span class="font10">preferably </span>
   <span class="font10">preference </span>
   <span class="font10">promising </span>
   <span class="font10">proteinase </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">range </span>
   <span class="font10">rapid </span>
   <span class="font10">reactive </span>
   <span class="font10">recently </span>
   <span class="font10">recombinant </span>
   <span class="font10">regulation </span>
   <span class="font10">replacement </span>
   <span class="font10">reported </span>
   <span class="font10">respectively </span>
   <span class="font10">seasonal </span>
   <span class="font10">segment </span>
   <span class="font10">short </span>
   <span class="font10">showed </span>
   <span class="font10">significantly </span>
   <span class="font10">single </span>
   <span class="font10">site, </span>
   <span class="font10">sticks </span>
   <span class="font10">structural </span>
   <span class="font10">suited </span>
   <span class="font10">sulfonylated </span>
   <span class="font10">syndrome </span>
   <span class="font10">synthesis </span>
   <span class="font10">synthesized </span>
   <span class="font10">targets. </span>
   <span class="font10">triad </span>
   <span class="font10">tribasic </span>
   <span class="font10">typical </span>
   <span class="font10">variant </span>
   <span class="font10">virus, </span>
   <span class="font10">viruses. </span>
   <span class="font10">water </span>
   <span class="font10">weak </span>
   <span class="font10">widely </span>
   <span class="font10">μM) </span>
   <span class="font10">μM. </span>
  </p>
 </body>
</html>
